rbs2418
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 19, 2022 (NCT05270213)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07175441 | Phase 2 | Oct 31, 2025 | Riboscience, LLC. |
| NCT06824064 | Phase 2 | Jan 17, 2025 | Riboscience, LLC., Tam Anh Research Institute |
| NCT05270213 | Phase 1 | Apr 19, 2022 | Riboscience, LLC. |
| NCT05683470 | N/A | — | Riboscience, LLC. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Riboscience, LLC. | For profit | 4 | 4 | 3 | 2022 |
| Tam Anh Research Institute | Academic/Hospital | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1